Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |